Wize Pharma (Israel) Performance

WIZP -- Israel Stock  

ILS 213.00  10.20  5.03%

Wize Pharma holds performance score of 23 on a scale of zero to a hundred. The firm maintains market beta of 0.0 which attests that the returns on MARKET and Wize Pharma are completely uncorrelated. Although it is essential to pay attention to Wize Pharma historical price patterns, it is also good to be reasonable about what you can actually do with equity current price history. Macroaxis philosophy towards determining future performance of any stock is to look not only at its past charts but also at the business as a whole, including all available fundamental and technical indicators. To evaluate if Wize Pharma expected return of 150.7294 will be sustainable into the future, we have found twenty-one different technical indicators which can help you to check if the expected returns are sustainable. Use Wize Pharma Semi Deviation, Coefficient Of Variation and the relationship between Mean Deviation and Downside Deviation to analyze future returns on Wize Pharma.
Horizon     30 Days    Login   to change

Wize Pharma Relative Risk vs. Return Landscape

If you would invest  21,300  in Wize Pharma on September 18, 2018 and sell it today you would earn a total of  0.00  from holding Wize Pharma or generate 0.0% return on investment over 30 days. Wize Pharma is generating 150.7294% of daily returns and assumes 417.8104% volatility on return distribution over the 30 days horizon. Simply put, majority of traded equity instruments are less risky than Wize Pharma on the bases of their historical return distribution and most equity instruments are likely to generate higher returns than the company over the next 30 trading days.
 Daily Expected Return (%) 
      Risk (%) 
Assuming 30 trading days horizon, Wize Pharma is expected to generate 391.28 times more return on investment than the market. However, the company is 391.28 times more volatile than its market benchmark. It trades about 0.36 of its potential returns per unit of risk. The DOW is currently generating roughly -0.08 per unit of risk.

Wize Pharma Market Risk Analysis

Sharpe Ratio = 0.3608
Good Returns
Average Returns
Small Returns
Negative Returns

Wize Pharma Relative Performance Indicators

Estimated Market Risk
  actual daily
 4 %
of total potential
Expected Return
  actual daily
 96 %
of total potential
Risk-Adjusted Return
  actual daily
 23 %
of total potential
Based on monthly moving average Wize Pharma is performing at about 23% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Wize Pharma by adding it to a well-diversified portfolio.

Wize Pharma Performance Rating

Wize Pharma Risk Adjusted Performance Analysis


Risk-Adjusted Performance

Compared to the overall equity markets, risk-adjusted returns on investments in Wize Pharma are ranked lower than 23 (%) of all global equities and portfolios over the last 30 days.

Wize Pharma Alerts

Equity Alerts and Improvement Suggestions

Wize Pharma is not yet fully synchronised with the market data
Wize Pharma appears to be very risky and stock price may revert if volatility continues
Wize Pharma has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
The company has accumulated 707 K in total debt with debt to equity ratio (D/E) of 217.9 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Wize Pharma has Current Ratio of 0.23 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
This company reported revenue of . Net Loss for the year was (1.91 M).
WIZE PHARMA has accumulated about 275 K in cash with (1.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.

Wize Pharma Performance Indicators

Wize Pharma Basic Price Performance Measures

Fifty Two Week Low190.40
Fifty Two Week High218.00
See also Your Current Watchlist. Please also try Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Search macroaxis.com